Lantheus submits drug master file for imaging biomarker

Lantheus Holdings, parent company of Lantheus Medical Imaging, said that it...Read more on AuntMinnie.comRelated Reading: Point Biopharma to use Lantheus' PyL in clinical trial Lantheus divests Puerto Rico nuclear medicine businesses FDA clears Lantheus' AI bone software Sofie, Lantheus ink deal for prostate cancer imaging agent Lantheus reports mixed Q3 results
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news